Neuronetics

We're hiring — explore open roles below and apply in a few clicks.

0 followers

www.neuronetics.com/

Location

Headquarters: Malvern, Pennsylvania, United States, North America

Region: Pennsylvania

Country: US

Continent: North America

About

Neuronetics is a company that specializes in developing and marketing medical devices for the treatment of psychiatric disorders, particularly depression. They offer a non-drug, non-invasive treatment called NeuroStar Advanced Therapy, which is a transcranial magnetic stimulation (TMS) treatment. The company is committed to improving quality of life for people suffering from psychiatric disorders and has a strong focus on patient-centric approach and customer support.

Neuronetics develops and markets medical devices for treating psychiatric disorders, primarily depression. Its flagship product, NeuroStar Advanced Therapy, is a non-invasive transcranial magnetic stimulation system prescribed to patients. The company serves healthcare providers and patients seeking non-pharmacological treatment options.

Legal Name:

Neuronetics, Inc.

Founded:

2003

Company Type:

for_profit

Operating Status:

active

Industries

Primary Industry: Manufacturing

Medical Devices & EquipmentMental Health & Rehabilitation FacilitiesPhotographic & Optical EquipmentTest & Measurement Equipment

Funding & Financials

Funding Stage:

Public Company

Total Funding:

$451.4M

IPO Status:

public

Stock Symbol:

NASDAQ:STIM

Stock Exchange:

NASDAQ

Investors

Perceptive AdvisorsSLR Capital PartnersJ Carlo CannellSolar capitalInvestor Growth Capital LimitedNew Leaf Venture PartnersAccuitive Medical VenturesIndustry VenturesONSET Ventures

Founders

Charles Epstein

Norman Weldon

Thomas D. Weldon

Leadership

Judy P. Ways — Vice President, Regulatory Affairs and Quality Assurance

Cory Anderson — VP Clinical Affairs and Medical Operations

Charles Epstein — Co-Founder & Managing Director

Daniel Reuvers — President and Chief Executive Officer

Matthew Rieke — Investor

Daniel Guthrie — Chief Commercial Officer

Bruce Shook — board_member

Brian Farley — board_member

Daniel Reuvers — board_member

Stephen Campe — board_member

Glenn Muir — board_member

Wilfred Jaeger — board_member

Chris Thatcher — board_member

Technology Stack

IPhone / Mobile CompatibleViewport MetaDNSSECGoogle Tag ManagerWordPressWordpress PluginsFont AwesomeIPv6Google MapsApache

Products

NeuroStar Advanced Therapy for Mental Health: A non-drug, non-invasive TMS treatment for major depressive disorder, utilizing precise magnetic stimulation to the brain areas involved in mood regulation.

TrakStar Practice Management System: A HIPAA-compliant system that captures treatment-relevant data, allowing for real-time analysis and management of patient information across devices.

MT Assist: A feature within NeuroStar that helps physicians determine the proper treatment dose and motor threshold unique to each patient, ensuring precise therapy delivery.

Contact Sensing: Technology that provides real-time feedback during treatment, ensuring the prescribed dose of therapy is consistently delivered to the patient.